Same Indication

Ipilimumab vs Memantine

Ipilimumab vs Memantine: Overview

This comparison examines the pharmacological differences between Ipilimumab and Memantine.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Memantine: Non-competitive NMDA receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Memantine β€” 60-80 hours.

Chemical Properties

Molecular Formula: Memantine β€” C12H21N.

Molecular Weight: Memantine β€” 179.3080 g/mol.

Type: Ipilimumab β€” Antibody; Memantine β€” Small molecule.